ArticleMolecular therapy. Oncology2026

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study.

Piyush Gondaliya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.